Pharma with UNC-Chapel Hill connection files $60M IPO
Seattle-based Immune Design Corp., a clinical-stage immunotherapy company whose technologies aim to See all stories on this topic
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Comments